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CANADIAN PRISON NEEDLE-EXCHANGE PROGRAMS:  




The incidence of HIV and Hepatitis C is significantly higher in Canadian 
federal penitentiaries than among the general public, as are the transmission 
rates of these two diseases. These disproportionate rates of infection are largely 
attributed to the sharing of needles among inmates who are addicted to 
intravenous drugs. This has created a serious public health risk for all federal 
inmates as well as the general public, since many of these inmates will be 
released back into society. In response to this risk, the Correctional Service of 
Canada asked the Public Health Agency of Canada (PHAC) to study the 
effectiveness and risks of prison needle-exchange programs (PNEPs). In 2006, 
PHAC’s report, “Prison needle exchange: Review of the evidence,” concluded 
that “[n]eedle-sharing practices decrease in prisons where PNEPs are offered.” 
Despite these findings, the federal government has refused to establish a prison 
needle-exchange program. 
The harm caused by the federal government’s continuing reluctance is 
compounded by an existing legislative prohibition on sterile needles in federal 
penitentiaries. In light of current political and legislative barriers, any hope of 
establishing such a program lies with the courts. This article assesses the ability 
to challenge the legislative prohibition on sterile needles through a claim under 
the Canadian Charter of Rights and Freedoms. 
Citation: (2015) 24 Dal J Leg Stud 25. 
                                                                                                                                            
*  Adrien Iafrate is a recent graduate of the Schulich School of Law at Dalhousie University. He would like to 
thank Professor Elaine Gibson for her guidance and feedback throughout the development of this article. 
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I. OVERVIEW 
In RJR-MacDonald Inc v Canada (Attorney General), Justice La Forest observed 
that “health underlies many of our most cherished rights and values, and the 
protection of public health is one of the fundamental responsibilities of 
Parliament.”1 The exercise of Parliament’s fundamental responsibility has 
stopped at the doorsteps of its federal penitentiaries. The prevalence of HIV and 
Hepatitis C (HCV) in federal penitentiaries “raises several concerns regarding the 
increased risk to uninfected inmates and to public health.”2 The concerns are 
largely attributed to the dangerous health risks faced by inmates who use needles 
to facilitate their drug addictions.3 While needle sharing is not unique to prison 
populations, the prohibition on clean needles in an environment with high rates 
of infectious diseases compounds the health risks. The potential risks spread 
beyond prison walls when infected inmates complete the custodial portion of 
their sentence and begin reintegrating into society. The Correctional Service of 
Canada (CSC) has several harm reduction strategies to combat this public health 
concern,4 but has stopped short of providing sterile needles. 
In April 2006, the Public Health Agency of Canada (PHAC) released a risk-
benefit analysis of prison needle-exchange programs (PNEPs) for CSC and 
reported that “needle-exchange programs for injection drug users in prisons 
reduce the need for health care interventions.”5 A needle-exchange program 
“denotes the one-to-one exchange of a used syringe (which includes a needle) for 
a new syringe.”6 The report analyzed similar programs from other jurisdictions to 
assess the practical implications of a Canadian initiative. It found that PNEPs 
could effectively reduce the transmission of HIV and HCV. However, PNEPs 
cannot be legally implemented in Canada given the current prohibition on 
                                                                                                                                            
1  RJR-MacDonald Inc v Canada (AG), [1995] 3 SCR 199 at para 69, [1995] SCJ No 68 (QL), La Forest J, 
dissenting [RJR-MacDonald]. 
2  Correctional Service of Canada, “Infectious Diseases in Canadian Federal Penitentiaries, 2000–2001”, by 
Prithwish De in FORUM on Corrections Research, vol 14, no 2 (Ottawa: CSC, 2002) [CSC, “Infectious 
Diseases”]. 
3  Ibid. 
4  Correctional Service of Canada, “Management of Infectious Diseases”, Commissioner’s Directive No 821 
(Ottawa: CSC, 23 December 2009). 
5  Wayne Kondro, “Conservative government scuttles needle exchange” (2007) 176:3 CMAJ 308. 
6  Ontario Medical Association, “Improving Our Health: Why is Canada Lagging Behind in Establishing 
Needle Exchange Programs in Prisons?” (Position Paper, 4 October 2004). 
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prisoners’ use of sterile needles in federal penitentiaries for non-medical 
purposes. Despite PHAC’s findings, former federal Minister of Public Safety 
Stockwell Day rejected the creation of a PNEP pilot project.7 On October 18, 
2013, seven years after the report’s publication, Public Safety Minister Steven 
Blaney reaffirmed the federal government’s opposition.8 The program was 
rejected on the basis of fiscal restraints,9 safety concerns, and the government’s 
“zero tolerance policy for drugs in [federal] institutions.”10 These statutory 
limitations, combined with the federal government’s unwillingness to implement 
this program, have resulted in PNEP proponents turning to the courts for justice. 
On September 25, 2012, a former federal inmate and several advocacy groups 
filed an application claiming that the lack of needle-sharing programs in federal 
penitentiaries violates the Canadian Charter of Rights and Freedoms.11 
This article examines the public health risk caused by sharing needles in 
Canadian penitentiaries and assesses the legal parameters of addressing this risk, 
specifically through needle-exchange programs. It begins by outlining the severity 
of the current public health risk caused by needle sharing among federal inmates. 
It then explores both current and prospective responses to eliminating the 
resultant public health risk. In addition, it explains the political and legislative 
barriers to implementing a needle-exchange program in Canadian penitentiaries. 
Finally, the last part analyzes the legal parameters for implementing a needle-
sharing program in Canadian penitentiaries through Charter litigation. Specifically, 
this part assesses whether the total prohibition on sterile needles—especially in 
cases where addiction has been diagnosed—infringes an inmate’s life, liberty, or 
security of the person in a manner inconsistent with the principles of fundamental 
justice, contrary to section 7 of the Charter. The ideal claimant for such a case is 
an inmate who is addicted to intravenous drugs. The severe health risks associated 
                                                                                                                                            
7  Kondro, supra note 5. 
8  Diana Mehta, “AIDS prevention groups want prison needle programs to protect inmates, public”, CTV 
News (18 October 2013), online: <www.ctvnews.ca/canada/aids-prevention-groups-want-prison-needle-
programs-to-protect-inmates-public-1.1502466>. 
9  Kondro, supra note 5. 
10  Mehta, supra note 8. 
11  Canadian Charter of Rights and Freedoms, Part I of the Constitution Act, 1982, being Schedule B to the Canada 
Act 1982 (UK), 1982, c 11, s 15 [Charter]. See also Notice of Application, infra note 17. 
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with a prohibition on sterile needles will likely engage an inmate’s life, liberty, and 
security of the person. Furthermore, the discord between the state’s objective in 
prohibiting the illicit use of needles and the potentially devastating effects on 
inmate health may cause these infringements to violate principles of fundamental 
justice. If PNEPs can provide a less drastic means of achieving the state’s 
objective to maintain a safe penal environment, an outright prohibition will be 
difficult to justify as minimally impairing under section 1 of the Charter. 
II. METHODOLOGY AND LIMITATIONS 
This article combines social science and legal research. An analysis of various 
government, scholarly, and non-governmental data was conducted to develop a 
balanced view of the public health risk currently present in federal penitentiaries. 
The research focused on sources published within the last ten years in order to 
ensure the analysis is accurate and relevant. After researching the public health 
risk, an analysis of possible remedies, including PNEPs, was undertaken, relying 
on Canadian and international sources. The political opposition to PNEPs was 
studied using online Canadian media reports. The remainder of the research 
involved an analysis of Charter jurisprudence to determine whether a Charter 
challenge could force the government to implement a PNEP.  
This article has four major limitations. First, the analysis is limited to 
Canadian federal penitentiaries and may not be applicable to provincial 
correctional facilities. While similar problems may arise in provincial institutions, 
the public health data is derived from federal penitentiaries and the legal analysis 
focuses on federal legislation. Second, the focus on PNEPs does not preclude the 
capacity of alternative measures, such as safe injection sites,12 to achieve the same 
objective. This paper focuses exclusively on PNEPs because they are prevalent 
in other countries and have been studied extensively by the Canadian 
government. While a safe injection site can arguably accomplish the same 
objective, there is limited research on its practical implementation in Canadian 
                                                                                                                                            
12  A safe injection site allows individuals to inject drugs under the supervision of nurses and other staff, 
whereas PNEPs simply allow inmates to exchange their used needles for sterile ones. Unlike a safe 
injection site, PNEPs do not require supervision from additional staff. 
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prisons.13 Third, this paper does not discuss any potential remedies to be obtained 
through judicial review. As will be discussed in Part VI, sterile needles are 
unauthorized unless a Commissioner’s Directive or an institutional head explicitly 
permits them. There is no indication that these administrative actors have 
explicitly denied a request to authorize sterile needles, which would open them 
up to a potential application for judicial review. Finally, this article focuses 
exclusively on legal arguments from Canadian domestic law to the exclusion of 
arguments based on international law. The Canadian government may also be 
required to fulfill obligations toward prisoners established by international laws 
and guidelines.14 
III. SOCIAL AND LEGAL CONTEXT 
Prison needle-exchange programs remain both a legally and politically 
contentious issue. As recently as October 2013, PNEPs made national headlines 
and prompted negative responses from the federal government. The current 
federal government remains strongly opposed to these programs, yet its reasoning 
directly contradicts the findings of PHAC.15 Despite rejecting PHAC’s findings, 
the government’s stance may resonate with the public. André Picard of The Globe 
and Mail believes that the “common reaction to the suggestion of prison needle 
exchanges is sputtering outrage” because, on its face, it legitimizes drugs in 
prisons and provides dangerous criminals with weapons.16 
While the debate surrounding PNEPs has been evolving over the last 
decade, it has not fully matured. The Ontario Superior Court of Justice 
                                                                                                                                            
13  Additionally, safe injection sites may be harder to establish through Charter litigation because they engage 
the Controlled Drugs and Substances Act, SC 1996, c 19, and the professionals administering the drugs could 
be held liable for possession of narcotics. 
14  The Ontario Medical Association argues that Canada’s obligations under the Universal Declaration of 
Human Rights, the International Covenant on Social, Economic and Cultural Rights, and the International 
Covenant on Civil and Political Rights require the federal government to offer syringe exchange programs 
to federal inmates: Ontario Medical Association, supra note 6. 
15  Public Health Agency of Canada, Prison needle exchange: Review of the evidence, Report for Correctional Service 
of Canada (Ottawa: April 2006) [PHAC, Prison needle exchange]. 
16 André Picard, “A call for pragmatism in clean-needle debate”, The Globe and Mail (1 October 2012), online: 
<www.theglobeandmail.com/news/politics/a-call-for-pragmatism-in-clean-needle-
debate/article4580629>. 
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application will not only force the debate into public headlines, it will also force 
the courts to reconsider the level of Charter protection afforded to federal 
inmates.17 This legal area is relatively limited and likely contentious. However, the 
movement toward PNEPs is gaining momentum and it may reach the Supreme 
Court of Canada in the next few years. 
IV. PUBLIC HEALTH RISK 
A.  Health Risk 
The high transmission rates of HIV and HCV in federal penitentiaries have 
been largely attributed to the sharing of unsterile needles for the purpose of 
injecting illegal narcotics.18 Although narcotics are illegal in prisons, it has been 
documented that “drugs remain widely available in prisons and a substantial 
proportion of prisoners consume them.”19 The high transmission rates are also 
caused by unprotected sexual activity and unsafe tattooing practices. These 
additional sources of HIV and HCV transmission increase the likelihood that new 
inmates will become infected and, consequently, elevate the risks of needle 
sharing. These trends threaten the health of inmates who share needles, as well 
as the larger penitentiary population and the public at large.  
The prevalence of HIV and HCV is disproportionately greater in federal 
penitentiaries than among the general population. In April 2006, PHAC released 
a report for CSC outlining the risks and benefits of PNEPs and the underlying 
problems concerning needle sharing. At the time, the prevalence of HIV in 
Canadian federal penitentiaries was between 1% and 8%, which was estimated to 
be 5 to 40 times higher than among the general Canadian population.20 The 
prevalence of HCV in penitentiaries was between 17% and 40%, or 20 to 50 times 
                                                                                                                                            
17  According to Canadian HIV/AIDS Legal Network, the Notice of Application to the Ontario Superior 
Court of Justice was filed on 25 September 2012. A copy of the Notice of Application can be found at 
<www.aidslaw.ca/site/wp-content/uploads/2013/04/PNSP_Notice-of-Application_FINAL-25-Sep-
2012.pdf> [Notice of Application]. 
18  CSC, “Infectious Diseases”, supra note 2. 
19  Thomas Kerr et al, “Harm reduction in prisons: a ‘rights based analysis’” (2004) 14:4 Crit Pub Health 345 
at 346. 
20  PHAC, Prison needle exchange, supra note 15 at 4. 
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higher than among the general population.21 Even at the lowest estimates, these 
numbers represent a drastic public health issue. CSC’s most recent figures 
estimate the HIV and HCV prevalence among federal penitentiaries to be 1.72% 
and 30.2% respectively.22 These numbers are consistent with the evidence 
presented by PHAC and demonstrate the disproportionate HIV and HCV rates 
in Canadian federal penitentiaries.23 A population with a drastically high rate of 
infectious diseases becomes a serious public health risk when it shares unsterilized 
needles. 
The health risk to individual inmates transforms into a public health risk when 
a specific population, namely inmates actively addicted to intravenous drugs, faces 
serious health concerns. Despite CSC’s efforts to keep federal penitentiaries free 
from illegal drugs, drug injection and needle sharing still occur. PHAC reported 
that 11% of federal inmates inject drugs during incarceration.24 CSC’s Summary of 
Emerging Findings from the 2007 National Inmate Infectious Diseases and Risk-Behaviours 
Survey found that 16% of male and 15% of female federal inmates reported 
injecting drugs while incarcerated.25 CSC’s survey also noted that 7% of male and 
5% of female inmates reported sharing needles while incarcerated.26 This research 
revealed that “among men, however, needle-sharing behaviours did not 
significantly decline in prison compared to the community.”27 PHAC concluded 
that the “available evidence strongly suggests that a large proportion of injection 
drug users who inject in correctional settings share (borrow and/or lend) needles 
                                                                                                                                            
21  Ibid. 
22  Public Health Agency of Canada, “Fact Sheet: People in Prison” (30 August 2012), online: <www.phac-
aspc.gc.ca/aids-sida/pr/sec4-eng.php> [PHAC, “Fact Sheet”]. The prevalence may be greater than 
reported because not all inmates undergo testing. 
23  Correctional Service Canada, Testing and Treatment for Human Immunodeficiency Virus and Hepatitis C Virus 
Infections among Canadian Federal Inmates by Dianne Zakaria et al (August 2010), online: <www.csc-
scc.gc.ca/research/005008-0223-eng.shtml> [CSC, Testing and Treatment]. These figures reflect the entire 
federal penitentiary population. The rates of federally-incarnated Aboriginal women are astonishingly high, 
as their reported rates of HIV and HCV infections are 11.7% and 49.1% respectively. 
24  PHAC, Prison needle exchange, supra note 15 at 19. 
25  Correctional Service of Canada, Summary of Emerging Findings from the 2007 National Inmate Infectious Diseases 
and Risk-Behaviours Survey (Ottawa: CSC, March 2010), online: <www.csc-scc.gc.ca/005/008/092/005008-
0211-01-eng.pdf> [CSC, Emerging Findings]. 
26  Ibid. 
27  Ibid. 
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and other injecting equipment.”28 An injection rate between 15% and 16% and a 
needle-sharing rate between 5% and 7% is significant when considering that there 
are over 14,000 incarcerated individuals in federal penitentiaries.29 In other words, 
approximately 1,000 incarcerated individuals reported sharing unsterile needles.30 
The public health risk becomes apparent when the high prevalence of HIV 
and HCV is considered in light of the needle-sharing rates. These factors 
“increase the probability of spreading [bloodborne viruses] in the prison 
setting.”31 The public health risk is heightened as the prevalence of these diseases 
in Canadian prisons has “been reported to be significantly higher for people who 
inject drugs.”32 Federal inmates who share unsterile needles for intravenous drug 
use face a serious risk of HIV or HCV infection. This risk can become a near 
certainty among certain vulnerable populations, such as female Aboriginal 
inmates, 50% of whom are infected with HCV.33 The sharing of unsterile needles 
in a population with high rates of HIV and HCV sets the stage for a serious public 
health crisis. 
The health risks created by the high rates of these diseases, combined with 
needle sharing among inmates, extend well beyond the prison walls. The PHAC 
and CSC reports indicate that individuals who do not have HIV or HCV upon 
incarceration have a high risk of becoming infected with these diseases by sharing 
needles in a federal penitentiary. This then becomes a risk to the general public 
because “most inmates are in prison only for relatively short periods of time and 
are then released into their communities.”34 An inmate who becomes infected 
with these diseases while incarcerated may transmit the disease to members of 
their community after he or she is released by sharing needles and engaging in 
unprotected sex. Neither PHAC nor CSC have published data concerning the 
                                                                                                                                            
28  PHAC, Prison needle exchange, supra note 15 at 19. 
28 Annual Report of the Office of the Correctional Investigator, 2012–2013 (Ottawa: 2013), online: <www.oci-
bec.gc.ca/cnt/rpt/pdf/annrpt/annrpt20122013-eng.pdf>. 
30  Ibid. As of 4 April 2013, there were 13,676 male inmates and 513 female inmates in federal penitentiaries. 
The approximate value of 1,000 is based on these numbers and their respective needle-sharing statistics. 
31 PHAC, Prison needle exchange, supra note 15 at 4. 
32  Sandra Chu, “Clean switch: the case for prison needle and syringe programs” (2009) 14:2 Can HIV/AIDS 
Pol’y & L Rev. 
33  See CSC, Testing and Treatment, supra note 23. 
34  Kerr et al, supra note 19 at 354. 
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rates of intravenous drug use and needle sharing among individuals released from 
federal custody. However, a longitudinal study conducted in Vancouver assessed 
the impact of incarceration on HIV risk factors for individuals released from 
prison. The sample was based on active injection drug users. The researchers 
found that “individuals recently released from prison were significantly more 
likely to report sharing contaminated syringes as compared to individuals who did 
not report incarceration.”35 Although the research focused on provincial 
correctional facilities and municipal jails in addition to federal penitentiaries, the 
findings paint a stark picture. Not only do federal inmates addicted to intravenous 
drugs face higher risks of becoming infected with HIV and HCV while 
incarcerated, they are also more likely to share needles once released. These 
findings underscore the breadth of the public health risk. 
B.  Health Impact  
Although advancements in medical treatments have reduced the health 
effects of HIV and HCV, both diseases can lead to severe medical complications. 
The health effects of these diseases can be grave: HIV weakens the body’s 
immune system and leads to life-threatening infections,36 while HCV causes 
serious complications such as “ascites (swelling in the abdomen), jaundice, or 
delayed blood clotting.”37 Fortunately for individuals diagnosed with these 
diseases, new treatments have reduced their impact. For example, HIV, albeit 
incurable,38 is now a treatable disease with combination antiretroviral therapy. 
This therapy can dramatically increase the life expectancy of individuals diagnosed 
with HIV, although their life expectancy remains lower than the general 
population’s.39 Similarly, HCV treatments can potentially suppress the virus, but 
                                                                                                                                            
35  M-J S Milloy et al, “Elevated HIV risk behaviour among recently incarcerated injection drug users in a 
Canadian setting: a longitudinal analysis” (2009) 9:156 BMC Public Health. 
36  CATIE, “HIV and AIDS Basics” (2015), online: Canadian AIDS Treatment Information Exchange 
<www.catie.ca/en/basics/hiv-and-aids> [CATIE, “Basics”]. 
37  CATIE, “Hepatitis C: An In-Depth Guide” (2015), online: Canadian AIDS Treatment Information 
Exchange <www.catie.ca/en/practical-guides/hepc-in-depth/living-hep-c/symptom-management>. 
38  CATIE, “Basics”, supra note 36. 
39  The average life expectancy among the general population is 80 years. See Muriel Draaisma, “Drugs 
increase life expectancy of HIV patients by 13 years: study”, CBC News (1 August 2008), online: CBC 
<www.cbc.ca/news/canada/drugs-increase-life-expectancy-of-hiv-patients-by-13-years-study-1.694961>. 
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their success depends on a variety of factors and may result in serious liver 
damage.40 These medical advancements, however, can only help individuals who 
have readily identified their infections and are receiving treatment. Unfortunately, 
these diseases are often not detected until medical complications have already 
occurred. In federal penitentiaries, the lack of mandatory testing for either virus41 
may result in an inmate’s infection going undetected. 
V. MEASURES TO COMBAT THE PUBLIC HEALTH RISK 
A.  Current Measures 
In response to this public health risk, CSC has implemented various 
educational and harm reduction strategies to address the negative health 
consequences of injection drug use. CSC’s current policy requires institutions to 
offer harm reduction educational programs and to provide bleach for inmates to 
obtain in a discreet manner.42 While these initiatives demonstrate a willingness to 
address the public health problem, they have limited effectiveness. PHAC found 
education to be a necessary tool, although, on its own, it is not sufficient as a 
harm reduction strategy. Furthermore, the World Health Organization concluded 
that “there is no good evidence supporting the effectiveness of bleach in the field 
in reducing HIV infection.”43 PHAC also disapproves of using bleach as an HCV 
prevention strategy in either the community or the prison context.44  
Meanwhile, CSC has implemented a methadone maintenance treatment 
program for opiate-addicted inmates.45 The program’s objective is to provide 
methadone orally as a substitute for opiate-based drugs, such as heroin. While 
this program has been associated with significant decreases in drug injection, it 
                                                                                                                                            
40  CATIE, “Hepatitis C: After Treatment” (2012), online: hepCinfo 
<www.hepcinfo.ca/en/detail/treatment/after-treatment>. 
41  Public Health Agency of Canada, “Fact Sheet: People in Prison” (30 August 2012), online <www.phac-
aspc.gc.ca/aids-sida/pr/sec4-eng.php>. The prevalence may be greater than reported because not all 
inmates undergo testing. 
42  CSC, “Infectious Diseases”, supra note 2. 
43  PHAC, Prison needle exchange, supra note 15 at 32. 
44  Ibid. 
45 Correctional Service of Canada, “Post Release Outcomes of Methadone Maintenance Treatment Program 
(MMTP) Participants: A Comparative Study” (1 July 2012), online: <www.csc-scc.gc.ca/research/005008-
err12-3-eng.shtml>. 
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can be inaccessible to inmates for several reasons. First, inmates may fail to meet 
the program’s admission and ongoing eligibility criteria, despite their opiate 
addiction. Second, the time required to process an application for the program 
creates a period where addicted inmates will try to satisfy their addiction through 
intravenous drug use. Finally, CSC limits the number of inmates who can receive 
this treatment. These three factors lead to “numerous situations where prisoners 
with a heroin addiction will continue to inject heroin and potentially engage in 
high-risk behaviours, despite the existence of [Methadone Maintenance 
Treatment] programs within the prison.”46 
The methadone maintenance treatment program’s ability to address the 
public health concern is also limited because it targets only individuals addicted 
to opiate-based drugs. CSC’s report reveals that many inmates inject cocaine.47 
However, methadone treatment does not target cocaine addictions; it only 
counteracts the use of opiate-based drugs like heroin. Therefore, inmates injecting 
cocaine will not benefit from the treatment and, consequently, will still rely on 
injecting drugs with needles. While the methadone program is an important 
element of the solution to this public health issue, its benefits cannot be fully 
realized if inmates continue to share unsterile needles. 
B.  Prison Needle-Exchange Programs 
The purpose of PNEPs is to eliminate the sharing of unsterile needles by 
supplying sterile needles to inmates. Sterile needles can be effectively distributed 
by using either the automatic dispenser model or the hand-to-hand distribution 
model. The automatic dispenser model provides inmates with a “dummy syringe” 
which can draw clean needles from a dispensing machine.48 Inmates must insert 
the syringe and needle in order to obtain a sterile needle. This model allows for 
easy access, a high degree of discretion, and an effective disposal system.49 By 
                                                                                                                                            
46  Rick Lines et al, Prison Needle Exchange: Lessons from a Comprehensive Review of International 
Evidence and Experience, 2d ed (Toronto: Canadian HIV/AIDS Legal Network, 2006) at 83. 
47  CSC, Emerging Findings, supra note 25.  
48  Lines et al, supra note 46 at 53. 
49  Ibid. 
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contrast, the hand-to-hand distribution model can be administered by prison 
medical staff, peer outreach workers, or external non-governmental 
organizations. While this option lacks discretion, it provides an opportunity to 
identify otherwise unknown drug users and helps to facilitate counselling.50 These 
programs both reduce an inmate’s likelihood of sharing unsterile needles. 
The public health risk caused by sharing unsterile needles in prisons is not 
unique to Canada. In fact, solutions employed by other countries provide useful 
insight. PNEPs have been implemented in various countries, including Armenia, 
Belarus, Germany, Iran, Kyrgyzstan, Luxembourg, Moldova, Portugal, Romania, 
Spain, and Switzerland.51 The European PNEPs have been successful as they are 
“associated with stable or decreased levels of drug use, declines in syringe sharing, 
as well as no new cases of HIV or hepatitis C infection.”52 At the request of CSC, 
PHAC commissioned a study on the potential risks and benefits of PNEPs. While 
PHAC found no definitive data concerning PNEPs’ impact on HIV and HCV 
transmission, it concluded that: 
• PNEPs do not lead to increased injection drug use; 
• Needle sharing practices decrease in prisons where PNEPs are offered; 
• Referrals to drug-treatment programs increase in prisons where PNEPs 
are offered; 
• Health care interventions related to injection site abscesses decrease in 
prisons where PNEPs are offered; and 
• The number of overdose-related health care interventions and deaths 
decrease in prisons where PNEPs are offered.53 
These findings are based on several European programs and favour the creation 
of a similar program in Canada. Data from international programs consistently 
suggests that PNEPs are effective at reducing the public health risks associated 
with needle sharing. 
                                                                                                                                            
50  Ibid at 52. 
51  Chu, supra note 32 at 1. 
52  Kerr et al, supra note 19 at 352. 
53  PHAC, Prison needle exchange, supra note 15. 
Vol. 24 Dalhousie Journal of Legal Studies 37 
	
VI. CURRENT IMPEDIMENTS TO PRISON NEEDLE-EXCHANGE PROGRAMS 
A.  Political Resistance 
Despite the benefits of PNEPs, they face strong political opposition in 
Canada based on three arguments: first, that the program will undermine the 
government’s zero tolerance drug policy in federal penitentiaries;54 second, that 
the government cannot justify spending public funds to implement this 
program;55 and, third, that PNEPs are inherently dangerous as they provide 
federally incarcerated inmates, who are serving sentences for relatively serious 
criminal offences, with dangerous weapons.56 While all three arguments are 
persuasive at first glance, a deeper analysis reveals their flaws.  
The government’s fear that PNEPs will undermine its zero tolerance drug 
policy ignores the realities of federal penitentiaries. In September 2012, then-
Public Safety Minister Vic Toews stated, “Our government has a zero tolerance 
policy for drugs in our institutions.”57 While drug possession is illegal throughout 
Canada and carries additional penalties in federal penitentiaries, the government’s 
zero tolerance policy does not change the fact that drugs remain widespread in 
Canadian prisons despite the best efforts of staff and policymakers.58 CSC 
implicitly acknowledges this reality through its bleach distribution program, 
which is designed to promote safe injection practices. The distribution of sterile 
needles has no effect on the government’s objective of preventing the smuggling 
of drugs into prisons. If the government could effectively rid their penitentiaries 
of illegal drugs, the distribution of sterile needles would be unnecessary. 
The government has also rejected PNEPs because they would be a costly 
and improper allocation of public resources. In response to PHAC’s 
recommendation, former Public Safety Minister Stockwell Day stated that a pilot 
                                                                                                                                            
54 Mehta, supra note 8. 
55  Kondro, supra note 5. 
56  Notice of Application, supra note 17. 
57  Anna Mehler-Paperny, “Inmates take Ottawa to court over access to clean needles”, The Globe and Mail (25 
September 2012), online: <www.theglobeandmail.com/news/politics/inmates-take-ottawa-to-court-over-
access-to-clean-needles/article4566054>. 
58  Kerr et al, supra note 19 at 346. 
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PNEP would be fiscally unjustifiable.59 While PNEPs require the government to 
finance sterile needles, a distribution system, and possibly additional staff, the 
total estimated costs are unclear. The Canadian HIV/AIDS Legal Network 
estimates that it costs $4,700 for a single automated syringe-dispensing machine.60 
In calculating the costs of creating a PNEP, it is not clear whether the Minister’s 
assessment includes the costs of HIV and HCV treatment. The Canadian AIDS 
Society estimates the lifetime healthcare costs for an individual infected with HIV 
to be $250,000.61 The total cost, accounting for factors such as quality of life and 
labour productivity, is estimated to be $1.3 million for each new diagnosis of 
HIV.62 Given the rates of infection and needle sharing, the long-term costs to the 
government can quickly escalate. Thus, $4,700 for an automated syringe-
dispensing machine pales in comparison to the millions of dollars spent on 
medical treatment. If a PNEP prevents even a single inmate from contracting 
HIV, then the government benefits financially. 
Lastly, the distribution of sterile needles to federal inmates has been strongly 
opposed by the government because it would allegedly provide inmates with 
dangerous weapons. The government fears that the needles could be used to 
injure other inmates and correctional staff, and would be even more dangerous if 
they are no longer sterile. Public Safety Minister Steven Blaney told the Canadian 
Press that his government “will never consider putting weapons, such as needles, 
in the hands of potentially violent offenders.”63 While the Minister’s concerns are 
by no means trivial, they must be assessed in light of the evidence. PHAC 
reported that the current body of research indicates PNEPs do not lead to: 
• PNEP syringes/needles being used as weapons; 
• increased altercations, whether between inmates or by inmates against 
prison staff; [or] 
                                                                                                                                            
59  Kondro, supra note 5. 
60  Lines et al, supra note 46 at 64. 
61  Lauryn Kronick, “Canadian AIDS Society: Cost of HIV is $1.3 million per person infected” (24 
November 2011), online: Canadian AIDS Society <www.cdnaids.ca/cost-of-hiv>. 
62  Ibid. 
63  Mehta, supra note 8. 
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• increased cases of needle-stick injuries.64 
These findings suggest that the Minister’s concerns are unfounded; yet, to be fair, 
the public health risk cannot be addressed at the expense of correctional staff and 
other inmates. Additional safety measures can and should be put in place to 
diminish, if not completely remove, the potential for violence. However, despite 
the evidence, the current government’s position is clear: PNEPs will not be 
introduced in federal penitentiaries. 
B.  Statutory Roadblocks 
While the government has no intention of creating a PNEP, the current 
prohibition on sterile needles in federal penitentiaries requires a sound legal basis. 
Outside of prisons, the needles used to inject narcotics are legally obtainable. In 
fact, community needle-exchange programs exist throughout Canada.65 However, 
the possession of needles in federal penitentiaries is illegal under the definition of 
either “contraband” in the Corrections and Conditional Release Act 66 or “unauthorized 
items” in the Corrections and Conditional Release Regulations.67 Under the Act, 
possession of contraband constitutes a summary conviction offence, whereas 
possession of unauthorized items is a disciplinary offence pursuant to the 
Regulations. The distinction between possessing “contraband” and possessing 
“unauthorized items” becomes significant when one assesses the constitutionality 
of their respective penalties. 
i. Contraband 
A needle is potentially illegal in federal penitentiaries if it falls within the 
definition of contraband in section 2(1) of the Act. If a needle meets the definition 
of contraband, then possessing it is both a disciplinary offence68 and a summary 
                                                                                                                                            
64  PHAC, Prison needle exchange, supra note 15 at 33. 
65  Lines et al, supra note 46 at 64. 
66  Corrections and Conditional Release Act, SC 1992, c 20, s 2(1) [Corrections Act]. 
67  Corrections and Conditional Release Regulations, SOR/92-620, s 2 [Corrections Regulations]. 
68  Corrections Act, supra note 66, s 40(i). 
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conviction offence.69 The two relevant definitions of contraband are contained in 
sections 2(1)(b) and 2(1)(e).70 These provisions define contraband to include: 
(b) a weapon or a component thereof, ammunition for a weapon, and 
anything that is designed to kill, injure or disable a person or that 
is altered so as to be capable of killing, injuring or disabling a 
person, when possessed without prior authorization; [and] 
[…] 
(e) any item not described [in this section] that could jeopardize the 
security of a penitentiary or the safety of persons, when that item 
is possessed without prior authorization.71 
While section 2(1)(e) seems most applicable to needles, one could argue that 
they also fall under section 2(1)(b). This section encompasses “anything” that is 
designed to inflict injury or anything that is altered to be capable of inflicting 
injury. While a needle is not a traditional weapon nor is it designed to inflict injury, 
it can be altered to inflict injury. However, since a needle is not designed to kill, 
injure, or disable someone, it probably does not fall under this section. 
If a needle does not fall under section 2(1)(b), then it will certainly fall under 
section 2(1)(e). Section 2(1)(e) defines contraband as any unauthorized item that 
could jeopardize the safety of a person. This definition creates a fairly low 
threshold, since a needle—or any sharp object—could certainly jeopardize the 
safety of other inmates and staff. The “prior authorization” requirement implies 
the existence of administrative discretion to authorize and prohibit items. Needles 
that receive “prior authorization” will no longer fall within the definition of 
contraband under section 2(1)(e). 
ii. Unauthorized Items 
A needle is also illegal in federal penitentiaries if it falls within the definition 
of “unauthorized item” under the Corrections Regulations. An “unauthorized item” 
is defined as “an item that is not authorized by a Commissioner’s Directives [sic] 
                                                                                                                                            
69  Ibid, s 45(a). 
70  The other three definitions of contraband are not relevant as they cover intoxicants, explosives, and 
currencies. 
71  Corrections Act, supra note 66, s 2(1). 
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or by a written order of the institutional head and that an inmate possesses 
without prior authorization.”72 Therefore, any such authorization must be 
explicit. Inmates found in possession of unauthorized items will have those items 
seized and may face disciplinary action. The latest Commissioner’s Directive 
regarding personal possession does not permit needles for either male or female 
inmates.73 There is no evidence that an institutional head has authorized needles 
and, given the Minister of Justice’s recent statements, it would appear that they 
are not authorized. If a needle receives authorization from the Commissioner or 
institutional head in the future, then it will no longer meet the definition of 
“unauthorized item” or “contraband” under section 2(1)(e) of the Act.74 
The statute and regulations provide ample options to prohibit needle use. If 
a needle meets the definition of contraband under section 2(1)(a), it will be 
prohibited by law. In addition, if a needle meets the definition of contraband 
under section 2(1)(e) of the Corrections Act or, alternatively, the definition of 
unauthorized item under section 2 of the Corrections Regulations, it will be 
prohibited by law subject to a contrary decision by the Minister or institutional 
head.  
VII. CIRCUMVENTING PARLIAMENT: CAN THE CHARTER  PROVIDE CHANGE? 
A.  State Action 
The current legislative and political roadblocks make a Charter challenge the 
only viable avenue to establish PNEPs in federal penitentiaries. Any potential 
Charter claim should not attempt to establish a positive right to PNEPs because 
the courts are unlikely to place positive obligations on the government through 
Charter litigation.75 Instead, the state’s prohibition on sterile needles for prisoners’ 
use in federal penitentiaries should be challenged. The ideal claimant for a Charter 
                                                                                                                                            
72  Corrections Regulations, supra note 67, s 2. 
73  Correctional Service of Canada, “Personal Property of Offenders”, Commissioner’s Directive No 566 12 
(Ottawa: CSC, 13 June 2012).  
74  The definition of contraband, under s 2(1)(e) of the Corrections Act, supra note 66, does not apply to items 
that have received authorization. 
75  Chaoulli v Quebec (AG), 2005 SCC 35, [2005] 1 SCR 791 [Chaoulli]. 
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challenge would be an inmate who is addicted to intravenous drugs because this 
would strengthen the causation analysis. In Canada (Attorney General) v PHS 
Community Services Society, the Supreme Court of Canada held that the 
government’s decision to close an existing safe injection site76 infringed section 7 
of the Charter. The court relied on the trial judge’s finding that “addiction is an 
illness, characterized by a loss of control over the need to consume the substance 
to which the addiction relates.”77 As a result, the court found that it was the 
government’s decision—not an individual’s drug use—that would cause 
potentially devastating health risks if the safe injection site were closed. The court 
rejected “Canada’s assertion that choice rather than state conduct is the cause of 
the health hazards [the safe injection site] seeks to address.”78  
The state’s prohibition on sterile needles in federal penitentiaries has a 
sufficient causative link with the harm suffered by the claimant in order to engage 
the Charter. In Canada (Attorney General) v Bedford, the Supreme Court held that the 
appropriate standard to determine causation for a section 7 Charter challenge is a 
“sufficient causal connection.”79 This standard “does not require that the 
impugned government action or law be the only or the dominant cause of the 
prejudice suffered by the claimant, and is satisfied by a reasonable inference, 
drawn on a balance of probabilities.”80 The standard is a flexible one and must be 
adapted in light of the circumstances of the case.81 In this case, the 
characterization of needles as “contraband” or “unauthorized items” has the 
practical effect of prohibiting sterile needles. This limits safe ways for inmates to 
satisfy their drug addiction and, in turn, fosters needle sharing. The added risk of 
harm caused by the prohibition constitutes sufficient causation to trigger Charter 
protection. Therefore, the state action in this case can be shown to engage the 
section 7 Charter rights of inmates addicted to intravenous drugs. 
                                                                                                                                            
76  The Minister refused to renew the safe injection site’s exemption under the Controlled Drugs and Substances 
Act. The decision would have effectively made the site illegal and forced its closure. 
77  Canada (AG) v PHS Community Services Society, 2011 SCC 44 at para 99, [2011] 3 SCR 134 [PHS Community 
Services]. 
78  Ibid. 
79  Canada (AG) v Bedford, 2013 SCC 72 at para 75, [2013] 3 SCR 1101 [Bedford]. 
80  Ibid at para 76. 
81  Ibid at paras 75, 78. 
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B.  Section 7 Engagement 
According to section 7 of the Charter, “Everyone has the right to life, liberty 
and security of the person and the right not to be deprived thereof except in 
accordance with the principles of fundamental justice.”82 The state’s prohibition 
on sterile needles engages an addicted inmate’s life, liberty, and security rights by 
encouraging needle sharing. The right to life may be engaged through the 
potentially lethal consequences of sharing a dirty needle. The right to liberty is 
engaged by the penal sanctions attached to possessing a clean needle. Finally, the 
right to security of the person, specifically bodily and psychological integrity, is 
engaged by the likelihood that inmates will contract one or more of these 
infectious diseases.83 Any deprivation of these rights must accord with the 
principles of fundamental justice, or else section 7 will have been violated. In 
other words, prohibiting sterile needles in prisons infringes the Charter if the 
state’s decision to do so is arbitrary, overboard, or grossly disproportionate. 
i. Right to Life 
An inmate’s right to life is engaged if the prohibition on sterile needles can 
result in death.84 In Chaoulli v Quebec (Attorney General), McLachlin C.J. and Major 
J. said that “[w]here lack of timely health care can result in death, section 7 
protection of life itself is engaged.”85 In Chaoulli, Quebec’s prohibition on private 
health insurance forced residents to endure excessive wait times for medical 
procedures, causing life-threatening risks. Similarly, the prohibition on sterile 
needles restricts safe options for injection and, in turn, can encourage inmates to 
share needles that are potentially infected with HIV and HCV. However, since 
HIV and HCV are both treatable viruses, it is unclear whether they engage the 
section 7 right to life. In PHS Community Services, preventing drug users from using 
the safe injection site’s “lifesaving and health-protecting services”86 engaged this 
                                                                                                                                            
82  Charter, supra note 11, s 7. 
83  PHS Community Services, supra note 77 at para 93. 
84  Chaoulli, supra note 75 at para 72. 
85  Ibid at para 123. 
86  PHS Community Services, supra note 77 at para 92. 
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right. However, unlike clean needles, the safe injection site additionally reduced 
the risk of overdoses. Nevertheless, if the health risks stemming from HIV and 
HCV do not engage the right to life, they may still engage the right to liberty and 
to security of the person. 
ii. Right to Liberty 
The punitive sanctions attached to possessing a sterile needle engage two 
dimensions of an inmate’s right to liberty. Firstly, if sterile needles are classified 
as contraband, the possession of a sterile needle is a summary conviction offence 
under section 45 of the Corrections Act, and carries a maximum term of six months’ 
imprisonment.87 The potential for additional prison time engages a core 
individual liberty interest.88 Secondly, if sterile needles are an “unauthorized 
item,” then the possession of a sterile needle constitutes a disciplinary offence 
under section 40(j) of the Corrections Act, which may carry penalties such as fines, 
loss of privileges, and segregation. The effect on the manner in which a sentence 
is served also affects an inmate’s liberty interest.89 While this liberty interest is 
clearly engaged, physical restraint in the penal context often engages liberty rights 
in a manner that complies with the principles of fundamental justice.90 
iii. Right to Security of the Person 
The state’s decision to prevent inmates from accessing sterile needles affects 
their bodily and physical integrity91 as well as their psychological integrity.92 An 
inmate’s bodily and physical integrity is engaged by the increased harm caused by 
prohibiting clean needles. This prohibition denies inmates the opportunity to 
safely inject intravenous drugs and, consequently, increases the risk that they will 
                                                                                                                                            
87  Under s 34(2) of the Interpretation Act, RSC 1985, c I-21, a federal enactment that creates a summary 
conviction offence is subject to all the provisions of the Criminal Code, RSC 1985, c C-46. Section 787(1) of 
the Criminal Code says “everyone who is convicted of an offence punishable on summary conviction is 
liable to a fine of not more than five thousand dollars or to a term of imprisonment not exceeding six 
months or to both.” 
88  R v Clay, 2003 SCC 75 at para 3, [2003] 3 SCR 735. 
89  Cunningham v Canada, [1993] 2 SCR 143 at para 14, [1993] SCJ No 47 (QL). 
90  Sauvé v Canada (Chief Electoral Officer), 2002 SCC 68 at para 47, [2002] 3 SCR 519, Gonthier J dissenting 
[Sauvé ]. 
91  PHS Community Services, supra note 77 at para 93. 
92  Chaoulli, supra note 75 at para 116. 
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share needles to satisfy their addiction. The high infection and transmission rates 
in federal penitentiaries, especially among intravenous drug users, increase the 
likelihood that inmates will contract HIV or HCV through needle sharing. The 
state’s needle prohibition mirrors the ban on private health insurance in Chaoulli 
and the refusal to permit a safe injection site in PHS Community Services, as all three 
instances involve a state decision resulting in severe health risks to the public. 
The prohibition on sterile needles may also affect an inmate’s psychological 
integrity. This argument will succeed only if an inmate can establish that the 
prohibition on sterile needles, and the subsequent risk of infection, leads to 
“serious state-imposed psychological stress.”93 The serious psychological effects 
“need not rise to the level of nervous shock or psychiatric illness, but must be 
greater than ordinary stress or anxiety” in order to engage section 7 of the 
Charter.94 In Chaoulli, the psychological harm suffered by individuals experiencing 
delays for medical treatment was held to engage section 7.95 Surely the risk of 
contracting a disease requiring lifelong treatment must at least match the suffering 
in Chaoulli.  
The addictive nature of the injected drugs may worsen the effect on an 
inmate’s psychological integrity. In R v Malmo-Levine, the Supreme Court rejected 
the argument that the criminalization of marijuana infringed the claimant’s 
psychological integrity. The court based its decision in part on evidence 
concerning the addictiveness of marijuana. The court reasoned: “The 
appellants…contend that use of marihuana is non-addictive. Prohibition would 
not therefore lead to a level of stress that is constitutionally cognizable.”96 Unlike 
marijuana, an inmate’s addiction to intravenous drugs might rise to this level of 
stress. Assuming that inmates have already managed to acquire illegal and 
addictive drugs, the prohibition on sterile needles prevents safe injection practices 
and places them in the position of either resisting their addiction or unsafely 
                                                                                                                                            
93  R v Morgentaler, [1988] 1 SCR 30, 44 DLR (4th) 385, Dickson CJ. 
94  Chaoulli, supra note 75 at para 116, citing New Brunswick (Minister of Health and Community Services) v G (J), 
[1999] 3 SCR 46 at para 60, [1999] SCJ No 47. 
95  Chaoulli, supra note 75 at para 117. 
96  R v Malmo-Levine, 2003 SCC 74 at para 88, [2003] 3 SCR 571 [Malmo-Levine]. 
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injecting the drugs, both of which may negatively impact their psychological 
integrity. 
iv. Conclusions on the Threshold Question 
The jurisprudence suggests that the prohibition on sterile needles will, at the 
very least, engage an inmate’s section 7 rights. This threshold analysis places little 
weight on the fact that the potential claimant is serving a criminal sentence and is 
actively in possession of narcotics while incarcerated.97 However, the engagement 
of life, liberty, or security of the person does not constitute an infringement of 
section 7 if the state action was carried out “in accordance with the principles of 
fundamental justice.”98 The courts have generally given deference to the state by 
allowing it to incarcerate individuals who commit criminal offences.99 In Sauvé v 
Canada (Chief Electoral Officer), McLachlin C.J. highlighted this trend when she 
stated that “certain rights are justifiably limited for penal reasons, including 
aspects of the rights to liberty, security of the person, mobility, and security 
against search and seizure.”100 
The public health risk caused by the prohibition on sterile needles and recent 
Charter jurisprudence may make it harder to justify the prohibition as being in 
accordance with the principles of fundamental justice. Firstly, the engagement of 
the right to life carries significantly more weight in the infringement analysis. 
McLachlin’s C.J.’s statement quoted above stops short of saying that penal 
reasons may justifiably limit the right to life. Secondly, and more importantly, PHS 
Community Services provides a novel approach to assessing the principles of 
fundamental justice. Although the facts are substantially different, the decision 
effectively authorizes a creative solution to the epidemic of infectious diseases 
caused by needle sharing. In light of the public health risk, the following pages 
assess whether the state’s prohibition on sterile needles accords with the 
                                                                                                                                            
97  Bedford, supra note 79 at para 90. 
98 Charter, supra note 11, s 7. 
99  Debra Parkes, “A Prisoner’s Charter? Reflections on Prisoner Litigation Under the Canadian Charter of 
Rights and Freedoms” (2007) 40 UBC L Rev 629. 
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principles of fundamental justice, particularly the rules against arbitrariness, 
overbreadth, and gross disproportionality. 
C.  Principles of Fundamental Justice 
i. Arbitrariness 
An arbitrary limit on an individual’s right to life, liberty, or security of the 
person violates the principles of fundamental justice. In Bedford, the Supreme 
Court said that a law is arbitrary when it imposes limits on an individual’s section 
7 interests “in a way that bears no connection to its objective.”101 In order to 
determine whether a state limitation is arbitrary, the law’s objective must first be 
identified. The next step is to identify “the relationship between the state interest 
and the impugned law”102 or, in this case, the impugned “contraband” and 
“unauthorized item” provisions.103 The purpose of this step is to determine 
whether the prohibition on sterile needles is rationally connected to the state’s 
objective. The connection between the state’s objective and the law’s effect is the 
key consideration. 
The state interest in prohibiting sterile needles in federal penitentiaries can 
be deduced from the Minister of Public Safety’s media comments and the larger 
aims of the Corrections Act. The purpose of the Corrections Act is partly defined in 
section 3: 
3.  The purpose of the federal correctional system is to contribute to 
the maintenance of a just, peaceful and safe society by 
 (a)  carrying out sentences imposed by courts through the safe 
and humane custody and supervision of offenders; and 
 (b)  assisting the rehabilitation of offenders and their 
reintegration into the community as law-abiding citizens 
through the provision of programs in penitentiaries and in 
the community.104 
                                                                                                                                            
101  Bedford, supra note 79 at para 111. 
102  PHS Community Services, supra note 77 at paras 129–130. 
103  Corrections Act, supra note 66, s 2(1); Corrections Regulations, supra note 67, s 2. 
104 Corrections Act, supra note 66, s 3. 
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The Corrections Act is primarily focused on maintaining public safety and ensuring 
the humane treatment of inmates. It also emphasizes effective rehabilitation as a 
means of successfully reintegrating inmates into the community. Furthermore, 
section 70 of the Corrections Act imposes a positive duty on federal penitentiaries 
to ensure the “the living and working conditions of inmates and the working 
conditions of staff members are safe, healthful and free of practices that 
undermine a person’s sense of personal dignity.”105 Together, sections 3 and 70 
establish the purpose of the Corrections Act: the maintenance of public and 
offender safety. 
In light of the Corrections Act and the Minister’s recent comments, one may 
reasonably infer that the state’s objective in prohibiting sterile needles in federal 
penitentiaries is to maintain a safe penal environment by eliminating illegal drugs 
and potentially lethal weapons. Since the state can rely upon either drug or 
weapon prevention to underpin its penal safety objective, the merits of each will 
be addressed separately. The state’s objective in prohibiting drugs was addressed 
in the context of marijuana possession in Malmo-Levine:  
The criminalization of possession is a statement of society’s collective 
disapproval of the use of a psychoactive drug such as marihuana… 
and, through Parliament, the continuing view that its use should be 
deterred. The prohibition is not arbitrary but is rationally connected to 
a reasonable apprehension of harm.106 
Though the prohibition of drugs is therefore a valid objective, it cannot extend 
to sterile needles. The prohibition on sterile needles is not connected to the 
federal penitentiaries’ desire to maintain a zero-drug policy. The availability of 
needles will neither positively nor negatively influence the smuggling of drugs into 
federal institutions. The state’s objective of maintaining a zero-drug policy in 
federal penitentiaries fails the arbitrariness test. The prohibition on sterile needles 
bears no connection to the objective of maintaining a safe penal environment by 
enforcing a zero-drug policy.107 
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106 PHS Community Services, supra note 77 at para 130, citing Malmo-Levine, supra note 96 at para 136. 
107 Bedford, supra note 79 at para 111. 
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Alternatively, the state’s objective in prohibiting sterile needles in federal 
penitentiaries may be to maintain a safe penal environment by eliminating 
potentially deadly weapons. Although PHAC and other reports suggest that 
needles have not been used as weapons in European PNEPs, the government’s 
concern appears reasonable from a common-sense perspective. The potential for 
needles to be used as deadly weapons places the safety of other inmates and 
correctional staff in jeopardy. This concern is connected to the objective of penal 
safety. While the prohibition on sterile needles affects the safety of needle-sharing 
inmates, it does not detract from the state objective. The state must undertake 
the difficult task of balancing inmates’ rights with the potential for harm to staff 
and other inmates. As a result, courts will afford deference to the state’s preferred 
means of achieving its objective. So, despite the specious means chosen to 
advance the government’s drug prevention objective and in light of these safety 
concerns, the effect of the prohibition on an inmate’s life, liberty, and security of 
the person is probably not arbitrary in the constitutional sense. 
ii. Overbreadth 
If there is no rational connection between the purpose underlying the 
prohibition on sterile needles and some of its effects, the law is overbroad.108 An 
overbroad law “is so broad in scope that it includes some conduct that bears no 
relation to its purpose.”109 Unlike the arbitrariness analysis, overbreadth applies 
when the purpose is rationally connected in some cases, but overreaches in its 
effects in other cases. This principle is more comprehensive than arbitrariness 
since it only requires the effect on a specific individual to bear no relation to the 
law’s purpose. To be sure, this analysis is not concerned with “competing social 
interests or ancillary benefits to the general population.”110 These concerns are 
relevant at the section 1 justification stage.  
The prohibition on sterile needles in federal penitentiaries arguably goes too 
far and thus violates an inmate’s section 7 rights “in a manner unconnected to 
                                                                                                                                            
108  Ibid at para 112. 
109  Ibid at para 113. 
110  Carter v Canada (AG), 2015 SCC 5 at para 85, 66 BCLR (5th) 215 [Carter]. 
50 PRISON NEEDLE-EXCHANGE PROGRAMS Vol. 24 
the law’s objective.”111 The law facilitates an environment where inmates who are 
addicted to intravenous drugs must share syringes in order to satisfy their drug 
addictions. The means chosen to achieve the state’s objective of maintaining a 
safe penal environment increases these inmates’ risk of contracting both HIV and 
HCV. The devastating effect on these inmates bears no relation to the law’s 
objective of maintaining a safe penal environment. The prohibition on sterile 
needles is therefore overbroad. 
iii. Gross Disproportionality 
The deprivation of an individual’s life, liberty, or security of the person will 
be grossly disproportionate when the state action or legislation is “so extreme as 
to be disproportionate to any legitimate government interest.”112 A gross 
disproportionality claim places a high burden on the claimant because it “only 
applies in extreme cases where the seriousness of the deprivation is totally out of 
sync with the objective of the measure.”113 In Malmo-Levine, the Supreme Court 
examined the relationship of proportionality between the state action and the 
state interest: 
The aspect of proportionality of interest to the appellants is the alleged 
lack of proportionality between the contribution of the marihuana 
prohibition to public health and safety…and the adverse effects on 
persons subject to the prohibition… The relevant effects include those 
that relate to the life, liberty or security of an individual, and that are 
the product of the state action complained of.114 
The onus is on the plaintiff to establish this claim, and the standard is one of gross 
disproportionality. 
The disproportionality between the prohibition on sterile needles and the 
effects on inmates addicted to intravenous drugs is quite significant. While this 
principle of fundamental justice places a high burden on the claimant, it also 
provides an opportunity to adduce medical and social science research on the 
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severe public health risks caused by needle sharing. This argument also requires 
a comparison to the state’s objective of protecting staff and other inmates by 
prohibiting potentially deadly weapons, and invites the claimant to put forward 
evidence showing the negative effects of this prohibition. While the burden is 
high, the gross disproportionality analysis may establish a section 7 infringement 
because of the serious health risk that the prohibition imposes on individuals 
addicted to intravenous drugs. 
D.  Section 1 
Section 1 of the Charter empowers the government to reasonably limit 
Charter rights if such limits “can be demonstrably justified in a free and democratic 
society.”115 Once a section 7 breach is established, the burden shifts to the 
government under section 1 to prove that the law’s negative impact on inmates 
addicted to intravenous drugs “is proportionate to the pressing and substantial 
goal of the law in furthering the public interest.”116 Unlike the individual 
assessment under section 7, the section 1 analysis focuses on the overarching 
public goal.117 The infringement is justified if the prohibition is prescribed by law, 
the law has a pressing and substantial objective, and the means chosen are 
proportional to that objective.118 The law is proportional if: (1) the prohibition is 
rationally connected to government’s objective; (2) it minimally impairs an 
inmate’s section 7 Charter rights; and (3) there is proportionality between the 
deleterious and salutary effects of the law.119 The government can easily establish 
that the limit is prescribed by law and that the law has a pressing and substantial 
objective. The main inquiry is whether the prohibition on sterile needles is 
proportional. 
The government can probably establish a rational connection by showing “a 
causal connection between the infringement and the benefit sought on the basis 
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of reason or logic.”120 In Alberta v Hutterian Brethren of Wilson Colony, the Supreme 
Court declared the “government must show that it is reasonable to suppose that 
the limit may further the goal, not that it will do so.”121 In Carter v Canada (Attorney 
General), the Supreme Court confirmed, “where an activity poses certain risks, 
prohibition of the activity in question is a rational method of curtailing the 
risks.”122 In this case, the government’s prohibition on sterile needles curtails the 
risk of needles being used to threaten the safety of correctional staff and other 
inmates. 
However, the government may not be able to demonstrate that the 
prohibition minimally impairs an inmate’s section 7 rights. Its failure to do so 
would render the prohibition unconstitutional. At this stage, the government 
must demonstrate “the absence of less drastic means of achieving the objective 
‘in a real and substantial manner.’”123 The government would likely argue that 
there are no feasible alternatives for ensuring staff and inmate safety that are 
equally as effective as a total prohibition. In response, a potential claimant must 
demonstrate how alternative methods can better achieve the state’s objective. 
Specifically, a claimant should introduce extensive evidence concerning the 
effectiveness of PNEPs, relying on PHAC’s study and examples from other 
jurisdictions. This evidence must demonstrate how PNEPs address inmate and 
public safety in a way that does not infringe an inmate’s rights to life, liberty, and 
security of the person. Although the burden remains on the government, a 
successful Charter claim is contingent on a claimant demonstrating that “there are 
less harmful means of achieving the legislative goal.”124 This would prevent the 
government from justifying the section 7 infringement as a reasonable limit under 
section 1. 
Finally, if the government succeeds at the minimal impairment stage, the 
infringement will likely be justified under the last branch of the proportionality 
analysis. A finding that the prohibition is minimally impairing of an inmate’s 
section 7 rights would effectively mean that PNEPs are not as safe of an 
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alternative to the current prohibition on needles. Moreover, it means that the 
prohibition is reasonably necessary to protect against needles being used as 
weapons against staff and other inmates. In this context, it is unlikely that the 
public health risk caused by the prohibition is so great as to outweigh the benefits 
of protecting staff and other inmates from this threat.  
VIII. CONCLUSION 
The prohibition on sterile needles in federal penitentiaries continues to pose 
a serious health risk for inmates addicted to intravenous drugs. The public health 
risk to this population has the ability to endanger the health of other prisoners 
and the general public. The abundant research by PHAC, CSC, and various others 
supports the idea that this poses a public health risk. This research not only 
describes the ineffectiveness of the government’s current responses, but 
advocates for the creation of PNEPs. Given the undeniably high rates of HIV 
and HCV in federal penitentiaries, the time has come to explore this option.  
The creation of a prison needle-exchange pilot project would be a sensible 
solution to the public health problem. In August 2005, CSC created a safe-
tattooing pilot project in six federal institutions to address the risks caused by 
unsafe tattooing practices.125 Although the pilot project was eventually terminated 
two years later,126 it demonstrated the government’s receptiveness to applying a 
unique solution to a major health problem. Unfortunately, the current 
government is not receptive to exploring innovative solutions to the current 
health risk caused by prison needle sharing. The current prohibition on needles 
also suggests that neither the Commissioner of CSC nor any institutional heads 
are inclined to exercise their statutory authority to address this problem. Any hope 
for change therefore lies in a court challenge. 
A successful challenge to the prohibition on sterile needles must include 
evidence at the trial stage underscoring the public health risks. In PHS Community 
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Services, the Supreme Court gave substantial deference to the trial judge 
concerning the benefits of a safe-injection site and the harms that would arise 
from its closure. The severity of the public health risks caused by closing a safe-
injection site in Vancouver’s Downtown Eastside fundamentally influenced the 
Supreme Court’s analysis of arbitrariness and gross disproportionality. The 
overwhelming evidence concerning the risks caused by prohibiting this public 
health initiative ultimately overweighed any legitimate state objective. If the 
prohibition on sterile needles in federal penitentiaries constitutes a Charter 
infringement, then the resolution must follow the approach taken in PHS 
Community Services. A successful claimant must emphasize the serious health risk 
facing federal inmates and remind the government of its duty to ensure the living 
conditions of inmates are “safe, healthful and free of practices that undermine a 
person’s sense of personal dignity.”127 Given the current state of the law, it should 
be relatively easy to show how the prohibition engages an inmate’s right to life, 
liberty, or security of the person. The real analysis lies at the principles of 
fundamental justice and section 1 justification stages. Ultimately, proof that the 
legislation is overbroad and does not minimally impair an inmate’s section 7 
Charter rights is the key to a successful claim. 
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